Ads
related to: pimobendan 2.5mg for dogs
Search results
Results From The WOW.Com Content Network
Pimobendan is indicated for the management of the signs of mild, moderate, or severe congestive heart failure in dogs due to clinical myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM); [1] [7] and for use with concurrent therapy for congestive heart failure (e.g.,furosemide, etc.) as appropriate on a case-by-case basis. [1]
phenylpropanolamine – controls urinary incontinence in dogs; phenytoin/pentobarbital – animal euthanasia product containing phenytoin and pentobarbital; pimobendan – phosphodiesterase 3 inhibitor used to manage heart failure in dogs; pirlimycin – antimicrobial; ponazuril – anticoccidial
UpCard-CA1 (torsemide oral solution) was conditionally approved for use with concurrent therapy with pimobendan, spironolactone, and an angiotensin-converting enzyme (ACE) inhibitor for the management of pulmonary edema (fluid build-up in lungs) in dogs with congestive heart failure caused by myxomatous mitral valve disease (MMVD). [17] [18]
Grapiprant is widely accepted in veterinary medicine due to its specific and targeted approach to pain management in dogs. The serum concentration of grapiprant is increased when used in conjunction with other drugs such as acetaminophen , albendazole , and alitretinoin .
Here are links to possibly useful sources of information about Pimobendan. PubMed provides review articles from the past five years (limit to free review articles ) The TRIP database provides clinical publications about evidence-based medicine .
Experimental studies on rats and dogs, proved the efficacy and mechanism of action of omecamtiv mecarbil. [4] Clinical studies on humans have shown there is a direct linear relationship between dose and systolic ejection time. [2] [13] [14] The dose-dependent effects persisted throughout the entire trial, suggesting that desensitization does ...
Ads
related to: pimobendan 2.5mg for dogs